If you have herpes, a combination of daily antiviral medication, condoms, and avoiding sex during outbreaks can reduce the chance of passing it to your partner by a significant margin. No single method eliminates the risk entirely, but layering these strategies together makes transmission far less likely than most people assume.
Understanding the Baseline Risk
Before thinking about protection, it helps to know what you’re working with. The per-act transmission risk for HSV-2 during sex is estimated at roughly 1.7%, averaged across all encounters (including days with and without viral shedding). On days when the virus is actively shedding, about 16% of sexual acts result in transmission. On days without shedding, the risk drops close to zero.
The virus sheds even when you have no symptoms. People with a history of outbreaks shed the virus on about 20% of days. People who carry HSV-2 but have never had noticeable symptoms shed on roughly 8 to 10% of days. This asymptomatic shedding is actually responsible for most transmissions, which is why relying solely on avoiding sex during visible outbreaks isn’t enough.
Daily Antiviral Medication
Taking a daily antiviral (most commonly valacyclovir) is one of the most effective tools for reducing transmission. In an eight-month clinical trial comparing daily valacyclovir to placebo, the medication reduced the risk of a partner developing symptomatic genital herpes by 75%. When accounting for both symptomatic infections and silent seroconversion (where the partner picks up the virus without obvious symptoms), the overall risk dropped by 48%.
Daily suppressive therapy also cuts outbreak frequency by 70 to 80%, which means fewer periods of high viral shedding. This is different from episodic treatment, where you take medication only when an outbreak appears. Episodic treatment shortens individual outbreaks but does little to reduce the day-to-day background shedding that drives most transmission. If protecting a partner is your goal, daily suppressive therapy is the stronger choice.
Condoms Make a Large Difference
Consistent condom use substantially lowers transmission risk, though the degree of protection depends on the direction of transmission. Condoms reduce per-act HSV-2 transmission from men to women by about 96%, and from women to men by about 65%. The difference likely reflects the fact that condoms cover more of the skin surface involved when a man is the source, while female-to-male transmission can involve skin contact in areas a condom doesn’t reach.
Condoms aren’t perfect for herpes because the virus can shed from skin around the genitals, thighs, or buttocks. But “not perfect” doesn’t mean “not worth it.” A 65 to 96% reduction in per-act risk is substantial, especially when combined with other strategies.
Avoiding Sex During Outbreaks
The simplest rule is also the most important: skip vaginal, anal, and oral sex when you have active sores, tingling, itching, or any other prodromal sensation that signals an outbreak is coming. Viral shedding is highest during and just before visible lesions appear, so this alone removes the highest-risk encounters from the equation. Wait until sores have fully healed and the skin looks normal again before resuming sexual contact.
Combining Strategies
Each of these methods works on its own, but the real power comes from stacking them. Consider a scenario where baseline annual transmission risk in a discordant couple might be in the range of 5 to 10% per year (depending on the direction of transmission and frequency of sex). Daily antivirals cut that roughly in half. Consistent condom use cuts it further. Avoiding sex during outbreaks removes the highest-risk days. Together, these three strategies can bring the annual risk of transmission down to low single digits or less.
There’s no published study that measures the exact combined effect of all three simultaneously, but each layer addresses a different part of the transmission pathway: antivirals reduce shedding frequency and viral load, condoms block skin-to-skin contact over the area they cover, and abstaining during outbreaks eliminates the peak shedding periods.
Oral Sex and HSV-1
Herpes protection isn’t only about genital-to-genital contact. HSV-1, which most people think of as cold sores, can spread from the mouth to a partner’s genitals during oral sex. This is now a common cause of new genital herpes infections. If you get cold sores, avoid giving oral sex during an active outbreak or when you feel the tingling that precedes one. Dental dams or condoms during oral sex reduce skin-to-skin contact, though they’re used less consistently in practice.
Getting Your Partner Tested
It’s worth finding out whether your partner already carries the same type of herpes you have. If they’re already seropositive for HSV-2, for example, they’re not at meaningful risk of “catching” it from you again. A type-specific IgG blood test can check for antibodies to HSV-1 and HSV-2 separately. The most reliable commercial tests have sensitivity above 93% and specificity in a similar range, though results are most accurate after antibodies have had time to develop (generally a few months after any potential exposure). A Western blot test is considered the gold standard if there’s any ambiguity in initial results.
One practical note: standard STI panels often don’t include herpes testing unless you specifically request it. Your partner may need to ask for it by name.
Talking to Your Partner
Disclosure is the foundation that makes every other strategy possible. Having the conversation before sexual contact begins, rather than in the heat of the moment, gives both of you time to ask questions and make informed decisions. Many couples find it helpful to have a healthcare provider involved in the conversation, particularly to clarify actual risk numbers, which tend to be much lower than people fear.
Encouraging your partner to speak with their own doctor can also be valuable. A provider can discuss whether type-specific testing makes sense, explain what the results mean, and help your partner understand their own existing HSV status. Many people discover they already carry one or both types without knowing it.
Special Considerations During Pregnancy
The stakes change significantly if your partner is pregnant or planning to become pregnant. A first herpes infection acquired during pregnancy, particularly in the third trimester, carries a real risk of neonatal herpes, which can be serious. If you’re HSV-positive and your pregnant partner is not, the standard approach includes all the usual precautions (daily antivirals for you, condoms, avoiding sex during outbreaks) with an even more conservative threshold. Some couples choose to avoid genital and oral sex entirely during the third trimester to minimize risk. This is a situation where working closely with an obstetrician is genuinely important, because the specific timing and combination of precautions can be tailored to your circumstances.
No Vaccine Yet, but the Toolkit Works
There is currently no approved vaccine for herpes, though several candidates are in various stages of development, including live attenuated viruses, mRNA-based approaches similar to some COVID-19 vaccines, and protein subunit vaccines. None have reached the market yet. For now, the combination of antivirals, condoms, outbreak avoidance, and open communication remains the most effective way to protect a partner. Used together consistently, these measures make transmission unlikely in most couples.